FGF23、orexin A、BMP-7在肾衰竭患者中的表达水平及与临床预后的关系

doi:10.3969/j.issn.1007-3205.2023.05.003

河北医科大学学报 ›› 2023, Vol. 44 ›› Issue (5): 512-516,546.doi: 10.3969/j.issn.1007-3205.2023.05.003

FGF23、orexin A、BMP-7在肾衰竭患者中的表达水平及与临床预后的关系

1.河北省廊坊市人民医院肾内科，河北廊坊 065000；2.河北省廊坊市人民医院检验科，河北廊坊 065000

出版日期:2023-05-25 发布日期:2023-05-25
作者简介:韩丽丽（1977-），女，河北大城人，河北省廊坊市人民医院副主任护师，医学学士，从事慢性肾病护理研究。
基金资助:
河北省医学科学研究课题计划（20221595）

Expression levels of FGF23, orexin A and BMP-7 in patients with renal failure and their relationship with clinical prognosis

1.Department of Nephrology, Langfang People′s Hospital, Hebei Province, Langfang 065000， China;
2.Department of Laboratory Medicine, Langfang People′s Hospital, Hebei Province,
Langfang 065000， China

Online:2023-05-25 Published:2023-05-25

摘要/Abstract

摘要： 目的探讨成纤维细胞生长因子23（fibroblast growth factor 23，FGF23）、食欲素A（orexin A）、骨形态发生蛋白7（bone morphogenetic protein-7，BMP-7）在肾衰竭患者中的表达水平及与临床预后的关系。
方法选取收治的肾衰竭患者65例为研究组，另选同期健康体检人群65例为对照组。研究对象均检测血液中FGF23、orexin A、BMP-7水平并进行比较分析；进行1年随访后，比较不同临床预后患者的临床资料，并分析FGF23、orexin A、BMP-7与肾衰竭患者临床不良预后的相关性；COX回归分析影响肾衰竭患者预后因素，分析FGF23、orexin A、BMP-7预测肾衰竭患者预后不良的接受者操作特性曲线(receiver operating characteristic curve，ROC）图。
结果与对照组比较，研究组FGF23、orexin A表达水平及血肌酐、尿酸、血尿素氮、C反应蛋白（C-reactive protein，CRP）水平较高，BMP-7表达水平较低（P＜0.05）；预后良好组48例，预后不良组17例，与预后良好组比较，预后不良组血肌酐、尿酸、血尿素氮、CRP、FGF23、orexin A表达水平较高，BMP-7表达水平较低（P＜0.05）；FGF23、orexin A与肾衰竭患者临床不良预后呈正相关，BMP-7与肾衰竭患者临床不良预后呈负相关（P＜0.05）；FGF23、orexin A是肾衰竭患者预后不良的独立危险因素，BMP-7是保护因素（P＜0.05）；FGF23、orexin A、BMP-7 AUC分别为0.920、0.697、0.849。
结论肾衰竭患者FGF23、orexin A表达水平较高，BMP-7表达水平较低，对肾衰竭患者的预后具有预测价值。

关键词: 肾功能不全, 成纤维细胞生长因子23, 食欲素A

Abstract: Objective To investigate the expression levels of fibroblast growth factor 23 (FGF23), orexin A and bone morphogenetic protein-7 (BMP-7) in patients with renal failure and their relationship with clinical prognosis.
Methods A total of 65 patients with renal failure were selected as the research group, and 65 healthy people who underwent physical examination during the same period were selected as the control group. The levels of FGF23, orexin A and BMP-7 in the blood of all subjects were detected, compared and analyzed. After 1-year follow-up, the clinical data of patients with different clinical prognoses were compared, and the correlation between FGF23, orexin A, BMP-7 and poor clinical prognosis of renal failure patients was analyzed. COX regression analysis was used to analyze prognostic factors in patients with renal failure, and the receiver operating characteristic curve (ROC) curve of FGF23, orexin A and BMP-7 in predicting poor prognosis in patients with renal failure was analyzed.
Results Compared with the control group, FGF23 and orexin A expression levels, blood creatinine(CREA), uric acid (UA), blood urea nitrogen (BUN) levels and C-reactive protein (CRP)were higher, while BMP-7 expression levels were lower in the research group (P<0.05). There were 48 cases in the good prognosis group and 17 cases in the poor prognosis group. Compared with the good prognosis group, patients in the poor prognosis group had higher expression levels of CREA, UA, BUN, CRP, FGF23 and orexin A and lower expression levels of BMP-7 (P＜0.05). FGF23 and orexin A were positively correlated with poor clinical prognosis in patients with renal failure, while BMP-7 was negatively correlated with poor clinical prognosis in patients with renal failure (P＜0.05). FGF23 and orexin A were independent risk factors for poor prognosis in patients with renal failure, and BMP-7 was a protective factor (P＜0.05). The AUC of FGF23, orexin A, and BMP-7 was 0.920, 0.697, and 0.849, respectively.
Conclusion The expression levels of FGF23 and orexin A in patients with renal failure are higher, and the expression level of BMP-7 is lower, which has predictive value for the prognosis of patients with renal failure.

Key words: renal insufficiency, fibroblast growth factor 23, orexins A

韩丽丽, 张平, 王芳, 陈珊珊, 扈瑞春, 张绍菊. FGF23、orexin A、BMP-7在肾衰竭患者中的表达水平及与临床预后的关系 [J]. 河北医科大学学报, 2023, 44(5): 512-516,546.

HAN Li-li, ZHANG Ping, WANG Fang, CHEN Shan-shan, HU Rui-chun, ZHANG Shao-ju. Expression levels of FGF23, orexin A and BMP-7 in patients with renal failure and their relationship with clinical prognosis [J]. Journal of Hebei Medical University, 2023, 44(5): 512-516,546.

[1]	范甜甜（综述）, 马哲（审校）. 牙周炎通过脂代谢途径促进慢性肾病发生发展的研究进展 [J]. 河北医科大学学报, 2023, 44(5): 596-601.
[2]	卢海源, 蒋海涛, 史国辉, 王国乙. 老年慢性肾衰竭维持性血液透析患者褪黑素、AOPP水平与骨质疏松症的关系研究 [J]. 河北医科大学学报, 2022, 43(7): 763-767.
[3]	陶晓阳, 李花, 郁胜强. β-CTX、UA、FGF-23与慢性肾衰竭透析患者矿物质-骨异常的关系[J]. 河北医科大学学报, 2021, 42(5): 531-535.
[4]	高田, 王淦楠, 王巍, 张劲松. 横纹肌溶解综合征肌红蛋白、肌酸激酶及其比值对急性肾功能衰竭的预测分析[J]. 河北医科大学学报, 2021, 42(4): 386-389，400.
[5]	李欣悦, 耿巍, 刘素芬, 田祥. 高敏肌钙蛋白T对慢性肾衰竭非透析患者急性心肌梗死的诊断价值[J]. 河北医科大学学报, 2021, 42(1): 12-16.
[6]	郭雪晶1，黄鹰1，张羽2*. Sema 3A、KIM-1和Cys C在子痫前期患者肾功能损害早期诊断中的临床价值[J]. 河北医科大学学报, 2019, 40(11): 1285-1289.
[7]	王妍妮1，解建国2. 后腹腔镜肾囊肿去顶减压术对多囊肾患者肾功能指标及主动脉根部内径的影响[J]. 河北医科大学学报, 2017, 37(8): 950-953.
[8]	姚〓律1,2，郝〓丽1*，郭长策2，丁士新2. 辛伐他汀对血液透析患者血浆组织因子和组织因子途径抑制物的影响[J]. 河北医科大学学报, 2017, 37(4): 390-394.
[9]	耿涛,戴士鹏,张建刚,徐泽升. 螺内酯对收缩性心力衰竭伴轻度肾功能不全患者的有效性和安全性研究[J]. 河北医科大学学报, 2016, 37(1): 13-17.
[10]	唐媛;周春霞. 对比剂急性肾损害的预防研究新进展[J]. , 2013, 34(4): 486-486.
[11]	梁碧荣;周林海;向馗;陈斌. 系统性红斑狼疮患者肺动脉压与肾功能损害程度的相关性研究[J]. , 2013, 34(3): 298-298.
[12]	霍树平;李亚;赵华宇;王秀丽;王秋筠. 不同程度控制性降压对全髋关节置换老年患者肾功能的影响[J]. , 2013, 34(11): 1415-1415.
[13]	黄然. 肌酐清除率用于早期发现社区老年高血压患者肾功能损伤的研究[J]. , 2012, 33(5): 550-550.
[14]	汪晓华;陈晓军. 胱抑素C在不同年龄组人群的差异性研究[J]. , 2011, 32(8): 916-916.
[15]	甄宇治;高延秋;刘超;刘刚;籍振国;刘坤申. 慢性心力衰竭急性加重伴2型糖尿病肾功能不全患者应用糖皮质激素的临床分析[J]. , 2011, 32(5): 509-509.

FGF23、orexin A、BMP-7在肾衰竭患者中的表达水平及与临床预后的关系

Expression levels of FGF23, orexin A and BMP-7 in patients with renal failure and their relationship with clinical prognosis

HTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价